Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
01 2FARMAK, a.s
02 1ChemWerth Inc
03 1LGM Pharma
04 1Jai Radhe Sales
05 1ALP Pharm
06 1Alcami
07 1Apicore LLC
08 3Enaltec Labs Private Limited
09 1Guangzhou Tosun Pharmaceutical
10 1Indoco Remedies Limited
11 1Lonza Group
12 1Micro Labs Limited
13 1SENJU PHARMACEUTICAL CO LTD
14 1Trifarma
15 1Viatris
16 1Yonsung Fine Chemicals
01 2China
02 2Czech Republic
03 7India
04 1Italy
05 1Japan
06 1South Korea
07 1Switzerland
08 4U.S.A
01 8Active
02 2Inactive
03 9Blank
01 19Blank
01 1223MF10031
02 1230MF10078
03 1306MF10119
04 16Blank
01 1WC-0110n
02 1WC-0152
03 1WC-0225
04 1WC-0424
05 1WC-0544
06 14Blank
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38922
Submission : 2023-10-18
Status : Active
Type : II
Registration Number : 306MF10119
Registrant's Address : Na vlcinci 16/3 Klasterni Hradisko 77900 Olomouc Czech Republic
Initial Date of Registration : 2024-09-03
Latest Date of Registration : --
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-17
Pay. Date : 2013-07-09
DMF Number : 24521
Submission : 2011-05-20
Status : Active
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
Registration Number : 230MF10078
Registrant's Address : Na vlcinci 16/3 Klasterni Hradisko 77900 Olomouc Czech Republic
Initial Date of Registration : 2018-07-03
Latest Date of Registration : --
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-04-23
Pay. Date : 2013-09-20
DMF Number : 25315
Submission : 2011-11-15
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-05-01
Pay. Date : 2013-04-16
DMF Number : 23031
Submission : 2009-07-31
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-04-04
Pay. Date : 2013-12-23
DMF Number : 27800
Submission : 2013-12-23
Status : Active
Type : II
Date of Issue : 2019-08-16
Valid Till : 2022-08-15
Written Confirmation Number : WC-0225
Address of the Firm :
NDC Package Code : 42571-281
Start Marketing Date : 2018-10-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16414
Submission : 2003-02-07
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-09
Pay. Date : 2013-08-28
DMF Number : 25245
Submission : 2011-08-18
Status : Active
Type : II
Date of Issue : 2019-07-15
Valid Till : 2022-07-15
Written Confirmation Number : WC-0152
Address of the Firm :
NDC Package Code : 14445-008
Start Marketing Date : 2013-12-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-01-27
Pay. Date : 2014-01-17
DMF Number : 23653
Submission : 2010-03-15
Status : Active
Type : II
Registration Number : 223MF10031
Registrant's Address : 207, Sujeong-ro, Jangan-myeon, Hwaseong-si, Gyeonggi-do, 18581, Republic of Korea
Initial Date of Registration : 2011-03-03
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10590
Submission : 1993-11-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22915
Submission : 2009-06-30
Status : Inactive
Type : II
Date of Issue : 2018-12-03
Valid Till : 2021-07-09
Written Confirmation Number : WC-0424
Address of the Firm :
NDC Package Code : 42413-0007
Start Marketing Date : 2011-05-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42413-0007
Start Marketing Date : 2011-05-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Date of Issue : 2022-07-15
Valid Till : 2025-07-02
Written Confirmation Number : WC-0110n
Address of the Firm :
NDC Package Code : 42973-144
Start Marketing Date : 2008-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2022-12-16
Valid Till : 2025-12-15
Written Confirmation Number : WC-0544
Address of the Firm :
NDC Package Code : 42413-0007
Start Marketing Date : 2011-05-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Bromfenac Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bromfenac Sodium, including repackagers and relabelers. The FDA regulates Bromfenac Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bromfenac Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bromfenac Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bromfenac Sodium supplier is an individual or a company that provides Bromfenac Sodium active pharmaceutical ingredient (API) or Bromfenac Sodium finished formulations upon request. The Bromfenac Sodium suppliers may include Bromfenac Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Bromfenac Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 16 companies offering Bromfenac Sodium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?